Our Research Team

Paul Warrick Schkolnik, Ph.D. is a psychologist with over 34 years of clinical and administrative experience in a variety of settings, including community mental health, corrections, and inpatient and outpatient drug treatment programs. He is currently the consulting psychologist and Chief Research Officer at Maryhaven. Since taking over for Dr. Brigham, Dr. Schkolnik has served as principle investigator for research conducted through NIDA and private corporations.

Back row, from left: Paul Schkolnik, Ph.D., Chief Research Officer; Monique Lumpkin, MSW, Research Institute Supervisor; Dr. Elizabeth Lottes, Research Physician; Kimberley Ross, MA, Research Assistant. Seated: Rachel Benge Glispie, RN, Research Nurse; Michelle Brenner, LPN, Research Nurse. Not pictured Tiffany Madden, MS, Doctoral Psychology Resident.

Back row, from left: Paul Schkolnik, Ph.D., Chief Research Officer; Monique Lumpkin, MSW, Research Institute Supervisor; Dr. Elizabeth Lottes, Research Physician; Kimberley Ross, MA, Research Assistant. Seated: Rachel Benge Glispie, RN, Research Nurse; Michelle Brenner, LPN, Research Nurse.

Dr. Schkolnik has provided program development and consultation services addressing juvenile sex-offending, adult and adolescent alcohol and other drug problems, and dual-diagnosis issues across the lifespan. Dr. Schkolnik received his B.A. from Carnegie-Mellon University and his M.A. and Ph.D. from the Ohio State University.

Monique Lumpkin, MSW, Research Institute Supervisor
Mrs. Lumpkin graduated from Huston-Tillotson University with a Bachelor’s Degree in Psychology, and received her Master’s Degree in Social Work from Washington University in St. Louis. Throughout her academic career, Mrs. Lumpkin has worked on research that included HIV/AIDS awareness, race relations, and increasing patient adherence. Mrs. Lumpkin officially began her research career as a Research Coordinator at The Cincinnati Children’s Hospital Medical Center, Cancer and Blood Disease Institute, Clinical Management and Research Support Core in 2007. Ms. Lumpkin managed multiple clinical trials sponsored by National Institutes of Health, National Heart, Lung, and Blood Institute. Mrs. Lumpkin was also honored to have an abstract, which she co-authored, be selected as a presentation at the First Global Congress on Sickle Cell Disease in Accra, Ghana. In her current role as Supervisor of The Maryhaven Addiction Research Institute, Ms. Lumpkin works towards improving upon addiction treatment through the conduct of multi-site clinical trials, sponsored by the National Institute on Drug Abuse.

Michelle Brenner, LPN
Research Nurse
ATP/ADOP Vivitrol Nurse

Kimberley Ross, MA
Research Assistant

Rachel Benge Glispie, RN
Medical Clinician